Lin Zhenhua, Gao Meihua, Zhang Xianglan, Kim Young-Sik, Lee Eung-Seok, Kim Han-Kyeom, Kim Insun
Department of Pathology, Korea University College of Medicine, Seoul, South Korea.
J Cancer Res Clin Oncol. 2005 Jun;131(6):364-70. doi: 10.1007/s00432-004-0657-5. Epub 2005 Mar 23.
This study is aimed at investigating the significance of gene promoter methylation status and protein expression of p16 INK4A and O6-methylguanine-DNA methyltransferase (MGMT) in the various uterine cervical lesions.
Methylation status by using methylation-specific polymerase chain reaction (MS-PCR) and protein expression by using immunohistochemistry for p16 INK4A and MGMT genes were performed in cervical squamous intraepithelial neoplasms (CIN), invasive squamous cell carcinomas (SCC), adenocarcinomas and non-neoplastic cervices.
None of 20 non-neoplastic cervices showed p16 INK4A and MGMT gene hypermethylation, whereas at least one of these genes was hypermethylated with 50.0% (5/10) of CIN I, 65.0% (13/20) of CIN II-III, 70.2% (33/47) of SCC and 85.0% (17/20) of adenocarcinoma. p16 INK4A protein was totally negative in non-neoplastic cervices, but positive with 90.0% of CIN I, 100% of CIN II-III and adenocarcinoma, and 78.7% of SCC. MGMT protein was expressed in 10% of non-neoplastic cervices, but significantly increased in SCC (42.5%) and adenocarcinoma (70.0%). The protein expression of p16 INK4A and MGMT was not related to their gene promoter methylation status.
The hypermethylation of p16 INK4A and MGMT genes in the uterine cervix may indicate the presence of malignant cells, and p16 INK4A immunostaining is useful in grading CIN and diagnosing invasive SCC and adenocarcinoma.
本研究旨在探讨基因启动子甲基化状态以及p16 INK4A和O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)蛋白表达在各种子宫颈病变中的意义。
采用甲基化特异性聚合酶链反应(MS-PCR)检测甲基化状态,并用免疫组织化学法检测p16 INK4A和MGMT基因的蛋白表达,检测对象包括子宫颈鳞状上皮内瘤变(CIN)、浸润性鳞状细胞癌(SCC)、腺癌以及非肿瘤性子宫颈组织。
20例非肿瘤性子宫颈组织均未显示p16 INK4A和MGMT基因高甲基化,而这些基因中至少有一个发生高甲基化的情况在以下病变中出现:50.0%(5/10)的CIN I、65.0%(13/20)的CIN II - III、70.2%(33/47)的SCC以及85.0%(17/20)的腺癌。p16 INK4A蛋白在非肿瘤性子宫颈组织中完全阴性,但在90.0%的CIN I、100%的CIN II - III和腺癌以及78.7%的SCC中呈阳性。MGMT蛋白在10%的非肿瘤性子宫颈组织中表达,但在SCC(42.5%)和腺癌(70.0%)中显著增加。p16 INK4A和MGMT的蛋白表达与其基因启动子甲基化状态无关。
子宫颈中p16 INK4A和MGMT基因的高甲基化可能提示恶性细胞的存在,p16 INK4A免疫染色有助于CIN分级以及浸润性SCC和腺癌的诊断。